Cholestatic liver diseases are among the most important liver disorders that occur in infants and children, leading to devastating morbidity and accounting for over 70% of liver transplants performed during childhood, thus posing a major public health burden. Although major advances in genetics of these disorders have been made over the past decade, few therapeutic options are available. Investigation of these disorders promises to advance scientific knowledge about hepatobiliary development, hepatocyte transporters, cholangiocyte biology, genetic regulatory networks, the neonatal immune response and mechanisms of injury, as well as the discovery of biomarkers of disease and testing of new diagnostic and therapeutic strategies. With the advent of next generation sequencing and genomics/epigenomics, disease modeling mathematical paradigms and a pipeline of new therapies, the potential translational impact of research in these disorders has never been greater. The 8 cholestatic disorders of the Childhood Liver Disease Research Network (ChiLDReN) have been studied in multi-centered research consortia at our Center for the past 11 years, during the last 5 years within ChiLDReN. Members of our Clinical Center at the University of Colorado Denver and Children's Hospital Colorado have played major leadership roles as the Chair of the Steering Committee of ChiLDReN and the Chair for the CFLD studies. The objectives of this grant application are for our site to be chosen as an active contributing Clinical Center in ChiLDReN;to continue to enroll new study subjects, follow current study subjects and retain subjects and fully implement, complete, analyze and publish all of the ChiLDReN study protocols;to be an active participant in the development of all new investigations, protocols and clinical trials initiated by the Network;to develop and propose new clinical and translational studies and ancillary studies that will utilize existing research subjecs, data and biospecimens, as illustrated by our proposed Scientific Research Plan;to oversee the CFLD studies and the CFLD network within ChiLDReN;to maintain leadership roles and some of the Administrative Functions of ChiLDReN and the CFLD network;and to continue to provide PFIC/BRIC Genotyping and Respiratory Chain Analysis expertise and services to the Network. Our Scientific Research Plan will elucidate the role of regulatory T-cells in human biliary atresia (BA), and determine if there are autoimmunity-associated SNPs in the gene FOXP3 present in BA and if these are related to the severity of BA. In these ways, our Clinical Center will enhance the ChiLDReN goals of promoting clinical and translational research in pediatric cholestatic liver diseases, focusing upon elucidating the pathogenesis and natural history and developing and testing novel therapeutics and clinical management strategies. Advances made by ChiLDReN should improve our understanding and clinical care of these important diseases and help to relieve an important public health burden.

Public Health Relevance

This study will help to discover new diagnostic tests, markers of disease activity and develop and test new treatments for children with rare liver diseases and those who undergo liver transplantation.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (M1))
Program Officer
Sherker, Averell H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Schools of Medicine
United States
Zip Code
Loomes, Kathleen M; Spino, Cathie; Goodrich, Nathan P et al. (2018) Bone Density in Children With Chronic Liver Disease Correlates With Growth and Cholestasis. Hepatology :
Bull, Laura N; Pawlikowska, Ludmila; Strautnieks, Sandra et al. (2018) Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies. Hepatol Commun 2:515-528
Ng, Vicky L; Sorensen, Lisa G; Alonso, Estella M et al. (2018) Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study. J Pediatr 196:139-147.e3
Alonso, Estella M; Ye, Wen; Hawthorne, Kieran et al. (2018) Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial. J Pediatr 202:179-185.e4
Bezerra, Jorge A; Wells, Rebecca G; Mack, Cara L et al. (2018) BILIARY ATRESIA: Clinical and Research Challenges for the 21st Century. Hepatology :
Carey, Alexandra N; Zhang, Wujuan; Setchell, Kenneth D R et al. (2017) Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates. Pediatr Res 82:122-132
Wang, Kasper S; Tiao, Greg; Bass, Lee M et al. (2017) Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology 65:1645-1654
Sundaram, Shikha S; Mack, Cara L; Feldman, Amy G et al. (2017) Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care. Liver Transpl 23:96-109
Tang, Vivian; Cofer, Zenobia C; Cui, Shuang et al. (2016) Loss of a Candidate Biliary Atresia Susceptibility Gene, add3a, Causes Biliary Developmental Defects in Zebrafish. J Pediatr Gastroenterol Nutr 63:524-530
Sokol, Ronald J (2016) Molecular Chaperones as Therapy for PFIC: Not So Fast! J Pediatr Gastroenterol Nutr 62:360-2

Showing the most recent 10 out of 63 publications